July 19, 2019

Blog

The story of Pumas

By Vijay Ivaturi

At the outset, I would like to acknowledge and thank all those who contributed to development of Pumas. Here is a complete list in no particular order:

Chris Rackauckas; Simon Byrne; Andreas Noack; Patrick Mogensen; José Bayoán Santiago Calderón; Yingbo Ma; Vaibhav Dixit; Xingjian Guo; Shubham Maddhashiya; Harrison Gordin; David Widmann; Joakim Nyberg; Joga Gobburu

I would also like to acknowledge the enthusiastic group of testers who put in time and effort to make this product better and are still working hard. Here is a complete list in no particular order:

Beatriz Gugleiri-Lopez; Joga Gobburu; Elyes Dahmane; Shamir Kalaria; Hechuan Wang; Praneeth Jarugula; Wansu Park; Mathangi Gopalakrishnan; Dinesh Bedathuru

How it all happened

March 2017

Pumas, along with choosing Julia Language to power it, was born out of a hallway discussion with a good friend and a gifted pharmacometrician, Joakim Nyberg during a coffee break at ASCPT conference in March 2017. As a first step, I reached out on Linkedin to Viral Shah, a co-creator of the Julia Language and the co-founder of Julia Computing. Viral, who is now a good friend and and collaborator was excited to learn about my interest to develop healthcare related tools in Julia Language and was immediately on board. I had mentioned to Viral that a lot of our systems require the use of differential equations and he introduced me to Chris Rackauckas, then a PhD student at UC Irvine. Chris blew my mind away with a detailed email, which was in his usual convincing way that I would soon find out about, that had the contents of exactly what I was looking for, and we immediately struck a chord. A small but important summary note:

Chris in his role as the project lead right from the beginning has built Pumas from ground up with a vision that will drive pharmacometrics tooling to new heights. Keep your eyes open.

June 2017

Viral and Chris put together a team to meet at JuliaCon 2017 in Berkeley, CA that could get started on building a prototype. This initial team had another stellar contributor to Julia Language and an amazing statistician, Simon Byrne who was working at Julia Computing. Pumas was originally started under an ambitious open source initiative called Osmosis. For many reasons beyond anyone's control, I decided to move Pumas under CTM's umbrella. It was probably the correct decision given the environment around product development in pharma. Our initial goal was to have a basic pharmacometric modeling engine that could simulate data using compartmental models and estimation using maximum likelihood methods.

Chris and I worked on setting up the simulation aspects while Joakim and Simon chugged away on the estimation methods. Personally, it was a fantastic learning experience.

October 2017

We had a working prototype as early as October and we decided to meet in person at Julia Computing's office in Boston to hash out further details. I was lucky to have had the shortest flight from Baltimore, while Simon and Chris flew in from LA and Joakim all the way from Sweden. The meeting was extremely productive and we came away with a finer blueprint of what we wanted.

The founding team of Pumas in Boston

March 2018

Work slowed down a bit over the holidays but we ramped it up just in time to have a fully working prototype ready by ASCPT 2018, where we met some stakeholders in Orlando to garner and assess interest. Long story short, we quickly realized that we were on our own without any support. However, we were really thankful for the meeting feedback as it helped us define our new directions. Moving ahead without further support would have been a real challenge, but it was right at that point that we found the three biggest supporters and believers in this project - Dr. Joga Gobburu, the CTM Director, Dr Jill Morgan, Chair, Pharmacy Practice and Science, and Dr. Natalie Eddington - Dean of University of Maryland School of Pharmacy. Their moral and financial support re-ignited the project and put us back on track.

Summer 2018

The Google Summer of Code (GSoC) had just begun and most of the Julia Language Community including Chris and Simon were busy mentoring students from around the world on various Julia projects. Chris recommended a few students who worked or were still working with him on the DifferentialEquations.jl ecosystem to join the project. I chatted with a few of them and eventually we had five students who joined the development team in July 2018.

Yingbo Ma and Xingjian Guo worked on the developing and enhancing the capabilities of the differential equation integration for pharmacometric models. They implemented and optimized many stiff ordinary differential equation solvers, and allowed the solvers to make use of automatic differentiation and adjoint sensitivity analysis for use in the estimation algorithms.

Vaibhav Dixit implemented the NLME estimation algorithms (Laplace, FOCE(I), FO) and the diagnostics. He also implemented the first prototypes for Bayesian estimation, along with a thorough investigation on efficient parameter estimation.

Shubham Maddhashiya worked on developing a neat package to facilitate Data Interpolations that form the backbone to handle time varying covariates. He is also the force behind the IVIVC module.

José Bayoán Santiago Calderón handled parsing and creating datasets in the NMTRAN format. He single handedly built the entire Bioequivalence.jl package that performs the simulation and analysis of all major BE designs including highly variable and narrow therapeutic index drugs.

October 2018

Thanks to the expanded team and the support from Joga and Natalie over the summer and early fall, we were feature rich to start putting our work out in the public. This resulted in our first poster at ACoP 2018. The poster received a ton of attention and we knew that we had a major task ahead of us -- to meet everyone's expectations, and our own too!

Harrison Gordin joined us in November 2018 to work on ModelingToolkit.jl, the symbolic backend library that makes it easy to add new features into the Pumas DSL.

We already had a working prototype for Non-Compartmental Analysis (NCA) by ACoP, but it was by no means ready for use. Bill Denney was generous enough by opening up the license for pknca to allow a Julia reimplementation. Yingbo volunteered and developed a Julia version of pknca in just 4 weeks. This was a massive boost to our project.

January 2019

Given the relatively large strides that we had taken, we were confident of putting out an alpha or beta release by late spring or early summer.

David Widmann joined us in early January 2019 to help with integration of Delay Differential Equations into Pumas, the core topic of his Master thesis.

This was the time when we started opening it up internally for testing to get feedback from CTM partners. We wanted to test Pumas's capabilities for Quantitative Systems Pharmacology (QsP) and wanted experts in this field to do this. Vantage Research's Rukmini Kumar and Vikram Prabhakar were kind enough to allow some of their fellows to volunteer their time. One of them, Dinesh, provided significant feedback that allowed really important changes to be made to the core.

March 2019

There was some change of guard happening at the estimation development front as Simon was moving on to a different project. In came Andreas Noack. It did not take long for the team to appreciate what Andreas brought to the table. Trained in statistics, Andreas had already contributed a lot to the JuliaStats world and is a fantastic addition to our team.

The team was in high spirits -- we had conducted extensive testing and were ready to make a public announcement to release Pumas shortly. Joga had received the prestigious Sheiner-Beal award in Pharmacometrics at ASCPT 2019, and revealed during his award speech that we would be releasing Pumas as early as mid-April.

Around the time of ASCPT, we had discussed with CJ Musante the possibility of testing Pumas or rather DifferentialEquations.jl at its core on some of the QsP models that Pfizer was working on in collaboration with Mount Sanai. Chris and Yingbo picked up this challenge and converted a Matlab based ~60-70 ODE model to Julia and did peformance testing. Note that this code in Julia was not optimized at all, and was just a straight translation at best. Julia was ~30x times faster in its un-optimized version comparted to the Matlab equivalent keeping all other factors the same.

This was the sort of verification we needed to tell us that we were on the right path.

May 2019

The team was in frantic preparation for an impending release with minor fixes and continuous testing. Just at this point, we were fortunate to have another outstanding addition to the team, Patrick Mogensen. Patrick is the lead developer of Optim.jl package, which is the backend for our estimation, and along with Andreas will have a major role to play going forward.

As a team we were ready to release Pumas, but just did not anticipate the time it would take to get all the paperwork sorted out to release a product developed at our University.

July 2019

JuliaCon 2019 is happening in Baltimore and we figured there was no better venue to release a Julia based product than here! All the delays and hurdles in releasing it early happened for a reason, and we are finally happy to see the release of Pumas on July 19, 2019.

And now...

This was a combined effort and I cannot imagine pulling off this project without this fantastic team. The end product is always a reflection of the quality of the team and I am proud and feel lucky to have worked with each one of these folks. Kudos also goes out to the whole Julia Community on creating one of the best environments for newcomers and creating a language so elegant while providing massive gains in efficiency in our analysis toolkit.

A special note goes out to Viral Shah and Deepak Vinchii of Julia Computing. They were patient as a saint and provided us a mechanism to work with students that Chris introduced us. It all started with a call, and now we are strategic collaborators on many fronts with a focused goal on providing better solutions for patient care, be it via pharmaceutical drug development innovation or tools for point of care. Thank you.

The journey to this point was thoroughly enjoyable and I hope to continue working with this team to develop products that are useful to the community. Spin some wheels with Pumas and let us know what you think. We are all ears!

Biographies

Chris Rackauckas is a senior research scientist at the University of Maryland, School of Pharmacy, and an applied mathematics instructor at the Massachusetts Institute of Technology. His research focuses on the development of efficient methods for solving pharmacological models, including PK/PD, PBPK, and QsP systems. His background in mathematical systems biology where his PhD work described how stochasticity (randomness) of chemical reactions can be controlled and utilized for patterning in the zebrafish hindbrain. Chris has also engaged in the research of new efficient methods for ordinary, stochastic, and partial differential equations. Along these lines, Chris Rackauckas is the lead developer of the JuliaDiffEq organization for numerical differential equation software which includes the flagship software DifferentialEquations.jl for which he won the Julia Community Prize in 2018.

Simon Byrne is a lead software engineer at Caltech. He has a Ph.D. from the University of Cambridge, 2011. Simon has expertise in management of large and distributed software projects, high-performance computing, statistics and machine learning

Andreas Noack has been a Julia contributor since 2012. His contributions have centered around numerical linear algebra but he has also contributed extensively to Julia’s statistics and parallel computing modules. After finishing his PhD in econometrics, Andreas joined professor Alan Edelman’s JuliaLab at MIT’s Computer Science and Artificial Intelligence Laboratory as a postdoc. During his time at MIT, Andreas collaborated with researchers from Berkeley, UCLA, Harvard, and the Broad Institute on projects ranging from statistical genomics to astronomy and Andreas has given talks on Julia at Stanford and UCLA. In 2017, Andreas joined Julia Computing as the Director of Research.

Patrick Mogensen is an economist with a research background in solving and doing inference of dynamic (discrete) choice models. Patrick has been part of the Julia community since 2015 and has made numerous contributions to the base language, as well as several popular packages, most notably Optim.jl, NLsolve.jl and LsqFit.jl.

José Bayoán Santiago Calderón is a postdoctoral research associate at the Biocomplexity Institute of the University of Virginia, in the Social and Decision Analytics Division. He holds a doctorate degree in economics from Claremont Graduate University. Bayoán has worked as a data scientist and research consultant for several years in the field of residential Demand Side Management (DSM) for utilities, developed and maintained computational economics materials as a lead developer at QuantEcon, and developed pharmaceutical software for the Pumas ecosystem. His research interests include quantitative methods, data science, and machine learning, applied to improving the decision-making of governments. In his spare time, he develops and contributes to open-source software such as packages for the Julia language.

Yingbo Ma was a math major in University of California, Irvine, and he is currently taking a gap year. He is a scientific computing intern in predictive healthcare analytics at Julia Computing, Inc. and the Center for Translation Medicine at the University of Maryland Baltimore. He is very interested in numerical treatments for differential equations and implemented a number of integrators and interfaces in JuliaDiffEq organization. His future goal is to develop new efficient algorithms for solving differential equations and to apply them in real practice.

Vaibhav Dixit is currently a junior undergraduate in Mathematics and Computing at Indian Institute of Technology (B.H.U.), Varanasi. He is mainly interested in understanding the physical world through mathematical models. He has been involved in applications of Statistical and Machine Learning techniques to analysis of dynamical systems modelled through differential equations. He is a contributor to DiffEqParamEstim.jl and DiffEqBayes.jl, both packages for Parameter Estimation and has also worked extensively on DiffEqSensitivity.jl for Sensitivity Analysis, these packages are a major part of the analysis tooling within the JuliaDiffEq suite.

Xingjian Guo was a part-time scientific computing intern in predictive healthcare analytics at Julia Computing, Inc. and the Center for Translation Medicine at the University of Maryland Baltimore. He helped with the development of PuMaS during his Master's studies in scientific computing at New York University. He is interested in the application of high performance computing tools to problems both in academia and in industry, especially those related to differential equations, inverse problems and optimization. He will soon begin working at SoundHound as cross-platform software engineer.

Shubham Maddhashiya is a third year undergraduate student majoring in Ocean Engineering and Naval Architecture at the Indian Institute of Technology, Kharagpur, India. Shubham is interested in artificial intelligence, and especially in its application in the field of robotics. He performs research on path planning and computer vision. Recently, Shubham gained interest in working on various aspects of scientific computing and deep learning. As a member of the Artificial Intelligence team at Kharagpur Robosoccer Student’s Group (KRSSG), he develops autonomous soccer playing robots and participates in international robotics competitions like RoboCup. In Google Summer of Code 2018, Shubham implemented the adaptive multistep method, the adaptive BDF and NDF methods and IMEX multistep methods under the project titled “Native Julia solver for ODEs and DAEs”. At CTM, Shubham is working on developing interpolation techniques that will be used in the larger realm of Clinical Trial Simulation for predictive health analytics.

Harrison Gordin Harrison Grodin is a computer science student at Carnegie Mellon University, with a focus on theoretical computer science and programming language theory. Within the Julia language community, his primary projects are within the domain of computer algebra. He is the author of Rewrite.jl, a principled term rewriting engine, and a core developer of ModelingToolkit.jl, a package for representing and manipulating systems of symbolic equations. He is working as a sceintific computing intern at Center for Translational Medicine and many of his contributions directly impact the Pumas DSL.

David Widmann is a PhD student at the Department of Information Technology and the Centre for Interdisciplinary Mathematics at Uppsala University, Sweden. The main focus of his research is uncertainty-aware deep learning, including the analysis and evaluation of calibration of probabilistic models. David obtained a medical degree and a master's degree in Mathematics from TU Munich. His master's thesis was centered at the numerical analysis of a biological model of delay differential equations and has been leading to many contributions to the JuliaDiffEq organization and in particular the numerical delay differential equation solver DelayDiffEq.jl.

Joakim Nyberg has a Ph.D. in Pharmaceutical Biosciences and M.Sc. in Engineering Physics Experience in system development and project management mainly with high security systems. His research focus is on practical and methodological optimal design. He is the primary developer of the optimal design tool PopED and worked with estimation methods for Pharmacometric models. He experience in therapeutic areas include diabetes, oncology, immunosuppressant and QT-prolongations. He is currently a team leader for a large phase III study, involving project management, QA/QC processes and data security

Joga Gobburu is a world-renowned scientific leader in the area of quantitative disease models and their applications to decisions. He is best known for transforming the field of pharmacometrics into a decision-supporting science. His experience as a senior biomedical research scientist and Director of Pharmacometrics at the Food and Drug Administration (FDA) gives him unique insight into the technical, regulatory, and decision-making aspects in all phases of drug development. He obtained his BPharm and MSc in chemistry from the Birla Institute of Technology and Science, his PhD in pharmaceutical sciences from North Dakota State University, and his MBA from Johns Hopkins University.

Vijay Ivaturi is a clinical pharmacologist and pharmacometrician by training and has worked on multiple drug development and clinical therapeutic programs. His primary research focus is on developing tools and methods to bridge the gap between decision makers and the scientists, with a special focus on clinical therapeutics in pediatrics. Some of the dosing algorithms he has developed are currently being used in pediatric hospitals around the country. Vijay is currently heading a team of scientists involved in democratizing tools and education, the two pillars of progress, for pharmaceutical research. He obtained his doctorate in experimental and clinical pharmacology from the University of Minnesota, which he followed with a post-doctoral fellowship in pharmacometrics at Uppsala University in Sweden.


twitter

In other News...

BLOG
A Journey of Passion and Innovation: Launching DeepPumas and AskPumasIn the world of tech, product launches are usually accompanied by discussions about cutting-edge algorithms, sleek interfaces, and revolutionary breakthroughs. But for me, the story of DeepPumas and AskPumas is not just about the technology—it’s about the people. It’s about how a global team, spread across 18 countries, came together to build something extraordinary.

In other News...

BLOG
AskPumas Surpasses 15,000 Questions Answered as Global Use of AI Tools in Drug Development AcceleratesAskPumas, our secure Retrieval Augmented Generation (RAG) tool built for clinical pharmacologists and pharmacometricians, has just surpassed 15,000 questions answered. AskPumas is an AI assistant that delivers trusted, on-demand access to field-specific knowledge by integrating a curated list of sources, giving pharmacometricians...

In other News...

BLOG
Collaborative work by Pumas-AI and Otsuka to be presented at NKF '21We are excited to announce that the collaborative work performed by Otsuka Pharmaceutical Development & Commercialization and Pumas-AI scientists will be presented at National Kidney Foundation 2021 on April 6-10, 2021! The modeling used Pumas software to explore urine osmolality and GFR relationship. Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term...

In other News...

BLOG
Congrats to Dr. Rackauckas – awarded 2020 ISoP Emerging Scientist!Dr. Christopher Rackauckas, our Director of Scientific Research, was recently awarded for the 2020 ISoP Emerging Scientist Award. The International Society of Pharmacometrics (ISoP) Awards Ceremony was hosted by the Eleventh American Conference of Pharmacometrics (ACoP11) on Monday, November 9, 2020. The Emerging Scientist Award, the highest early career award given by ISoP, was granted to...

In other News...

BLOG
Dr. Vijay Ivaturi Announced as New Chief Executive Officer at PumasAIThe PumasAI Board of Directors are pleased to announce that, effective Jan 1, 2024, Dr. Vijay Ivaturi will be stepping into the role of Chief Executive Officer, succeeding Dr. Joga Gobburu. After four years of dedicated leadership, Dr. Gobburu will be transitioning from his current role as CEO to the position of Chairman of the Board of PumasAI. Dr. Ivaturi brings a wealth of experience...

In other News...

BLOG
Former BMS Quality Director Joins Pumas-AI Scientists as Head of Quality Assurance and Compliance Amid 3X Growth PeriodPumas-AI, a science-first organization that turns data into life-saving decisions faster, announced today that Peter J. Miller has joined the organization as Head of Quality Assurance and Compliance. In his role, Mr. Miller will further strengthen and build upon the quality of deliverables and products that Pumas-AI scientists produce, including clinical pharmacology, pharmacometrics...

In other News...

BLOG
Former Bristol-Myers Squibb Head of Pharmacometrics Dr. Amit Roy Joins PumasAI to Support Drug Development Programs and DeepPumas ApplicationPumasAI, a science-first organization that turns data into life-saving decisions faster, announced today that Dr. Amit Roy, former Executive Director and Head of Pharmacometrics at Bristol-Myers Squibb (BMS), has joined PumasAI as Distinguished Scientist. In his new role, Dr. Roy will contribute to PumasAI’s growth trajectory by providing model-informed drug development (MIDD) expertise to accelerate drug development programs...

In other News...

BLOG
How Machine Learning Will Change the Future of Pharmaceuticals: Q&A with CEO Joga GobburuThe machine learning market is estimated to be worth a staggering $106.52 billion by the year 2030, according to Market Research Future. Combine this with the rise of consumer interest in artificial intelligence (AI) tools like ChatGPT, the world is beginning to mainstream these technologies. As this occurs, scientists are developing tools to level-up drug development analytics to create stronger outcomes and potentially save more lives...

In other News...

BLOG
International Society of Pharmacometrics Names Pumas-AI Co-Founder Dr. Vijay Ivaturi as President-ElectCo-Founder and Chief Scientific Officer (CSO) Vijay Ivaturi, PhD, has been elected as the next President of the International Society of Pharmacometrics (ISoP). Dr. Ivaturi will serve a one-year term as President-Elect effective immediately and will assume the ISoP presidency in January 2024, for a two-year term. As President-Elect, Dr. Ivaturi will oversee the development of ISoP’s three-year strategic plan...

In other News...

BLOG
Model-Informed Drug Development: Everything You Need to KnowAccording to the U.S. Food & Drug Administration (FDA), “model-informed drug development (MIDD) is an approach that involves developing and applying exposure-based, biological and statistical models derived from preclinical and clinical data sources to inform drug development and decision-making.” In 2018, the FDA created a pilot program to explore MIDD further...

In other News...

BLOG
New Clinical Pharmacology Desktop Software Launched by Pumas-AI is Easier to Use and Compliant with Global RegulationsPumas-AI, a science-first organization that turns data into life-saving decisions faster, announced today that it has launched Pumas-CP - a new clinical pharmacology platform for non-compartmental analysis (NCA), bioequivalence analysis, and pharmacokinetic and pharmacodynamic (PK/PD) modeling. “Pharmacokineticists and clinical pharmacologists are looking for a simple tool to manage...

In other News...

BLOG
New Three-Phase Course from PumasAI and SOPHAS on AI in Drug Development Set to Launch this OctoberPumasAI announced its partnership with SOPHAS (Society of Pharmacometrics and Health Analytics) to launch a new course aimed at empowering the next generation of scientists and healthcare professionals with practical knowledge on Artificial Intelligence in Drug Development (AIDD). This will be the first of many such courses being offered through this partnership.

In other News...

BLOG
Pharmacometrician Receives Lewis B. Sheiner Lecturer Award for Outstanding Lifetime AchievementsJoga Gobburu, PhD, a professor in the Department of Practice, Sciences, and Health Outcomes Research (P-SHOR) and director of the Center for Translational Medicine (CTM), received the Lewis B. Sheiner Lecturer Award, the highest recognition from ISoP on Nov. 5 at the society’s annual meeting at the National Harbor in Maryland.

In other News...

BLOG
The Future of Modelling and Simulations in Pharmacometrics with JuliaPharmacometricians have been early adopters of mathematical programming tools. We use tools that allow us to solve real problems. However, given the diversity of problems that we solve, our field has seen a split in the languages that we use due to the problems they are tailored to solve...

In other News...

BLOG
Powerful Pumas Software is Now Available for Desktop DownloadPumas-AI, a science-first organization that turns data into life-saving decisions faster, announced today that its Pumas software is now available for desktop download. Pumas is a one-stop integrated modeling and simulation platform designed to multiply productivity across the drug development lifecycle, turning data into life-saving decisions faster.

In other News...

BLOG
Pumas 2.8 Sets a New Standard for Clinical Pharmacology and Pharmacometrics Technology with Embedded AI and Next Generation EstimationPumasAI announced the release of Pumas version 2.8 to bring significant advancements in clinical pharmacology and pharmacometrics. The latest version integrates the recently launched PumasAide, enabling artificial intelligence (AI) coding agents to connect directly to live Pumas sessions, alongside powerful new estimation methods and expanded modeling capabilities.

In other News...

BLOG
Pumas-AI Continues to Expand Pharmaceutical Pharmacokinetics and Clinical Pharmacology Expertise with New Head of Business DevelopmentPumas-AI, a science-first organization that turns data into life-saving decisions faster, announced today that Dhanashri Gudi, Ph.D. has joined the company’s senior leadership team as Head of Business Development to continue to drive the year-over-year double-digit growth that Pumas-AI has experienced since inception. Dr. Gudi has spent nearly 20 years in the pharmaceutical industry, focused on drug metabolism...

In other News...

BLOG
Pumas-AI Hires Dr. Salim Bouchene and Expands Consulting Practice in EuropeThis new hire highlights expansions that Pumas-AI has made across the globe in recent years. As a senior scientist, Dr. Bouchene will focus on modeling and simulation and their application to pharmaceutical drug development. He will support Pumas-AI’s global client base through pharmacometrics and clinical pharmacology consulting, PK/PD modeling of clinical and preclinical data across various therapeutic areas...

In other News...

BLOG
Pumas-AI Launches Julia Language-Based Software to Advance Drug Development, Patient CarePumas-AI – a new company established by University of Maryland School of Pharmacy faculty members Vijay Ivaturi, PhD, assistant professor in the Department of Pharmacy Practice and Science (PPS), and Joga Gobburu, PhD, MBA, professor in PPS – is proud to announce the release of its first cutting-edge software platform for pharmaceutical researchers and clinicians. Known as Pharmaceutical...

In other News...

BLOG
Pumas-AI looks to democratize access to drug development toolsThe University of Maryland, Baltimore startup recently completed a big upgrade for its 2.0 version. Here's why the cofounders say it matters for science, and healthcare. For the cofounders of University of Maryland, Baltimore startup Pumas-AI, technology has the power to democratize access to advanced tools. The startup’s pharmaceutical modeling and simulation platform has two products...

In other News...

BLOG
PumasAI Brings AI, Scientific Machine Learning and Advanced Pharmacometric Research to ACoP 2026PumasAI announced its scientific program for the American Conference on Pharmacometrics (ACoP 2026), taking place October 11-14, 2026, at the Gaylord National Resort & Convention Center in Maryland.

In other News...

BLOG
PumasAI Helps Launch India's First Computational Lab for Quantitative Sciences to Advance AI in Drug DevelopmentPumasAI announced its role in helping to establish the Dr. Ramalingam Sankaran Computational Lab for Quantitative Sciences at PSG Institute of Medical Sciences and Research (PSGIMSR) in Coimbatore, India. Developed through a collaboration between...

In other News...

BLOG
PumasAI is Set to Revolutionize Pharmacometrics and Clinical Pharmacology with the Launch of AskPumas and DeepPumasPumasAI, a science-first organization dedicated to empowering innovation in drug development, today announced the launch of two transformative products: AskPumas and DeepPumas. Representing the first-ever intersection of AI and biosimulation, these tools are engineered to redefine pharmacometrics, clinical pharmacology, and data science. With unprecedented predictive capabilities...

In other News...

BLOG
PumasAI Launches New Clinical Pharmacology Webinar Series Showcasing End-to-End AI-Powered PK AnalysisPumasAI today announced the launch of PumasCP End-to-End, a new four-part educational webinar series designed to help clinical pharmacology professionals streamline pharmacokinetic (PK) analyses through a single reproducible environment enhanced with artificial intelligence (AI).

In other News...

BLOG
PumasAI Launches New Enterprise AI Transformation Service That is Proven to Help Pharmaceutical Teams Achieve 50% Productivity GrowthPumasAI today announced the launch of Catalyst, a new enterprise AI transformation service built to help pharmaceutical and biotech organizations achieve up to 50 percent productivity growth within 12 months through smarter AI adoption...

In other News...

BLOG
PumasAI Maintains Strong Growth Trajectory with New Product Engineering and Pharmacometrics Hires from JuliaHub and PfizerPumasAI, a pioneering organization at the forefront of transforming data into life-saving decisions with remarkable speed, is proud to announce the appointment of two distinguished leaders to its team. These strategic hires illustrate PumasAI’s dedication to accelerating the translation of complex data into impactful, life-saving strategies and solutions...

In other News...

BLOG
PumasAI Named Best Clinical Pharmacology Tech Innovator 2025 by Global Health and Pharma for the Second Year in a RowPumasAI announced today that it has been named Best Clinical Pharmacology Tech Innovator by Global Health and Pharma (GHP) in its Healthcare and Pharmaceutical Awards 2025 program. This marks the second year in a row that PumasAI has received this honor by the media publication.

In other News...

BLOG
PumasAI Named Best Clinical Pharmacology Technology Development Firm in Biotechnology AwardsPumasAI, a science-first organization and a trailblazer in clinical pharmacology technology, has been honored as the “Best Clinical Pharmacology Technology Development Firm” at the prestigious Biotechnology Awards, hosted by Global Health & Pharma. This accolade highlights PumasAI’s significant contributions to the pharmaceutical industry through its innovative approach and dedication

In other News...

BLOG
PumasAI Named Clinical Pharmacology & Pharmacometrics Innovator of the Year 2026 by Global Health & Pharma NewsPumasAI announced today that it has been named Clinical Pharmacology & Pharmacometrics Innovator of the Year 2026 by Global Health & Pharma (GHP) News as part of its annual Healthcare and Pharmaceutical Awards program. The recognition marks the third consecutive year that

In other News...

BLOG
PumasAI Now Offering its Modeling and Simulation Software Free to Academic Research InstitutionsPumas-AI Inc, a science-first organization that turns data into life-saving decisions faster, announced today that it is now opening its powerful modeling and simulation software to all global academic institutions and researchers free of charge. This pro-bono program provides the use of the Pumas® tool, a high-performance analytical software suite that allows users to perform all pharmaceutical modeling and...

In other News...

BLOG
PumasAI Unveils PumasAide, a Built-In AI Assistant to Accelerate Pharmacometric ResearchPumasAI has launched PumasAide, which connects the AI coding agent you already use directly to a live Pumas session. Working inside the IDE, it lets that agent analyze data, generate code, and run routine clinical pharmacology tasks against live models.

In other News...

BLOG
Q&A: Calling Oncology Trials Early - How DeepPumas Predicts NSCLC Outcomes From Interim DataIn this Q&A, we speak with Mohamed Tarek, PhD, Senior Product Engineer at PumasAI, about a recent application of DeepPumas: a joint tumor growth dynamics (TGD) and overall survival (OS) model for non-small cell lung cancer (NSCLC) that lets sponsors classify ongoing trials as likely successful or unsuccessful using only early interim data, well before traditional OS endpoints would be readable. Built on the DeepNLME framework and developed in close collaboration with scientists at Bristol Myers Squibb (BMS), the model came together in two phases: Mohamed laid much of the groundwork in 2023 and presented the first phase at ACoP 2024; his colleague Lorenzo Contento led the second phase, which was recently accepted as an oral presentation at PAGE 2026 in Dubrovnik, Croatia.

In other News...

BLOG
Researchers establish Pumas-AI, launch Pumas pharmaceutical softwarePumas-AI, a new company established by University of Maryland School of Pharmacy faculty members Vijay Ivaturi, PhD, assistant professor in the Department of Pharmacy Practice and Science, and Joga Gobburu, PhD, MBA, professor in the department, is proud to announce the release of its first...

In other News...

BLOG
UMB-born startup launches pharmaceutical modeling platform Pumas 1.0A startup launched out by faculty at University of Maryland, Baltimore and MIT researchers collaborated to launch Pumas 1.0, a predictive analytics platform that aids in the development cycle of pharmaceutical drugs. What that means is Pumas 1.0 takes the data a drug company has and simulates the success rate or possible outcome of a drug. Creating models and simulations through the algorithm...

In other News...

BLOG
UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support SystemPumas-AI, a University of Maryland, Baltimore (UMB) startup company, has been granted worldwide, exclusive rights to Lyv, a cutting-edge clinical decision support system designed to help health care professionals personalize treatment trajectories for patients in real-time. The Lyv platform leverages clinical research and Electronic Health Record (EHR) data from millions of patients to derive…

In other News...

BLOG
UMB Startup Pumas-AI Receives Exclusive LicensePumas-AI, a University of Maryland, Baltimore (UMB) startup company, has been granted worldwide, exclusive rights to enhancements to Pumas, an end-to-end pharmaceutical modeling and simulation platform for quantitative analysis across the drug development lifecycle. Pumas 2.0 builds on the company’s existing platform, which also employs technology licensed from UMB...

In other News...

BLOG
University of Maryland, Baltimore Researchers' Startup, Pumas-AI, Launches Cutting-Edge Healthcare SoftwarePumas-AI, a new University of Maryland, Baltimore (UMB) startup company established by University of Maryland School of Pharmacy (SOP) faculty members Vijay Ivaturi, PhD, assistant professor, and Joga Gobburu, PhD, MBA, professor, has released its first, cutting-edge software platform for pharmaceutical researchers and clinicians. Known as Pharmaceutical Modeling and Simulation (Pumas), the s...

In other News...

BLOG
Workshop on Quantitative Systems Pharmacology Workflows in Pumas to Advance Clinical Pharmacology and PharmacometricsPumasAI will have a major presence at the Quantitative Systems Pharmacology Conference (QSPC) 2026 in Leiden, the Netherlands. Created by PumasAI, these workshops will provide scientists with hands‑on, practical training in quantitative systems pharmacology (QSP) modeling and simulation workflows using Pumas™, supporting modern clinical pharmacology and pharmacometrics and enabling more informed, data‑driven decision‑making.

Leading businesses, research labs and universities choose us as their healthcare intelligence partners.

PumasAI News and Events
PumasAI.svg
Pumas-AI Inc.
3500 South Dupont Highway
Suite GT-101
Dover, DE 19901
Email: info@pumas.ai
twittertwitter
Pumas-AI Inc.
3500 South Dupont Highway
Suite GT-101
Dover, DE 19901
Email: info@pumas.ai
twittertwitter

© Pumas-AI Inc. 2026. All rights reserved.